Environmental

INMB’s disclosed R&D intensity is minimal in the provided metrics, which limits evidence of peer-leading low-carbon or resource-efficiency investment versus more disclosure-rich biotech peers.

The absence of reported gross profit margin and FCF margin in the supplied data reduces transparency on environmental cost drivers, leaving its footprint management harder to compare with peers.

Low leverage can indirectly support environmental resilience by preserving flexibility for compliance spending, but this is a weaker ESG signal than explicit emissions or energy disclosures.

No material environmental controversies or regulatory breaches were provided, so the company appears broadly neutral rather than advantaged relative to peers.

Social

The provided metrics do not show workforce, patient, or product-safety indicators, which limits evidence of stronger social positioning versus clinical-stage peers with fuller disclosure.

Minimal stock-based compensation relative to revenue suggests less dilution pressure on employees, but it is not a direct indicator of superior labor practices or retention.

Low leverage can support continuity of operations and stakeholder stability, yet peer comparison remains constrained without data on clinical conduct, access, or community impact.

No social controversies were supplied, so INMB appears neither clearly impaired nor clearly differentiated versus peers on the available evidence.

Governance

Debt-to-equity of 0.07 and net debt-to-EBITDA of 0.93 indicate conservative balance-sheet governance, which is generally stronger than more levered peers.

Zero reported stock-based compensation to revenue suggests restrained equity dilution, supporting shareholder alignment relative to peers that rely more heavily on compensation.

The lack of disclosed operating and profitability metrics in the supplied dataset weakens transparency, which keeps governance above average but below top-tier peer standards.

No governance controversies, restatements, or board failures were provided, so the main differentiator is prudent capital structure rather than exceptional oversight.

Overall Score

INMB’s ESG profile is broadly neutral to slightly above average versus peers, with governance supported by conservative leverage but limited by sparse environmental and social disclosure.

Score Driver: Conservative Leverage And Limited Disclosure Are The Main Relative Strengths, While The Absence Of Material E, S, And Governance Evidence Prevents A Stronger Peer-Ranking.